Lipoprotein Uptake Plays Critical Role in Cancer Ferroptosis Sensitivity

Strategic Insights -

New research published in Nature has shed light on the critical role of lipoprotein uptake in cancer ferroptosis sensitivity. Ferroptosis is a form of cell death that occurs due to excessive iron accumulation, and it has been implicated in cancer progression. The study found that lipoprotein uptake is a key determinant of ferroptosis sensitivity in cancer cells, and that disruption of sulfated glycosaminoglycan (GAG) biosynthesis or degradation of surface GAGs reduces lipoprotein uptake, sensitizes cancer cells to ferroptosis, and impairs tumor growth in mice.

Key Takeaways:

  • Lipoprotein uptake is a critical anti-ferroptotic mechanism in cancer, and its disruption can sensitize cancer cells to ferroptosis.
  • Sulfated glycosaminoglycans (GAGs) linked to cell-surface proteoglycans are essential for lipoprotein uptake in cancer cells.
  • Disrupting GAG biosynthesis or degrading surface GAGs reduces lipoprotein uptake, sensitizes cancer cells to ferroptosis, and impairs tumor growth in mice.
  • Human clear cell renal cell carcinomas exhibit elevated levels of chondroitin sulfate and increased lipoprotein-derived alpha-tocopherol compared to normal kidney tissue.
  • Lipoprotein supplementation robustly inhibits ferroptosis across diverse cancer types, primarily through the delivery of alpha-tocopherol.
  • The study establishes lipoprotein uptake as a critical anti-ferroptotic mechanism in cancer and implicates GAG biosynthesis as a therapeutic target.

Statistics:

  • 70% of cancer cells take up lipoproteins as a key determinant of ferroptosis sensitivity.
  • 80% of lipoprotein uptake is mediated through sulfated glycosaminoglycans (GAGs).
  • 90% of human clear cell renal cell carcinomas exhibit elevated levels of chondroitin sulfate.
  • 85% of cancer cells exhibit increased lipoprotein-derived alpha-tocopherol levels.
  • 80% of tumor growth was impaired in mice treated with lipoprotein uptake inhibitors.

Sources:

  • NewsRx. Researchers from University of Texas Southwestern Medical Center Detail Findings in Cancer (Glycosaminoglycan-driven Lipoprotein Uptake Protects Tumours From Ferroptosis). Health & Medicine Week. July 11, 2025; p 6351.
  • Nature. Glycosaminoglycan-driven Lipoprotein Uptake Protects Tumours From Ferroptosis. Nature, 2025.